Director, Global Hematology, Nephrology & Transplant Finance Business Partner

About the role

Alexion, AstraZeneca Rare Disease, is looking for a Director, Global Hematology, Nephrology & Transplant Finance Business Partner in Barcelona. Reporting to the VP, Global Head of Finance Commercial, the role leads the finance function for the Hematology, Nephrology and Transplant Global Leadership Team and partners with the Global Disease Area Head and the LT team to deliver a coherent strategy to the Senior Executive Team. The position is hybrid: 3 days in the office and 2 days working from home.

Key responsibilities

• Partner with the Global Disease Area Head and the Global Marketing and Market Access leadership team, and collaborate with senior global stakeholders to deliver a coherent strategy and a clear view of priorities and resource allocation.
• Lead franchise-level global performance tracking, insights and analytics monthly through the Management Business Review (MBR) meetings.
• Work with R&D Finance before investment decisions to understand the assumptions behind Phase 3 investments and propose new opportunities.
• Provide finance leadership to the TA team on strategy, prioritization and resource allocation, and lead the development of the Long-Term Plan and Middle-Term Plan forecasts.
• Lead the Quarterly Business Review (QBR) for the TA and anticipate investor relations questions.
• Manage and influence the TA/brand P&L and performance against budget, supporting optimal resource allocation across products, indications and markets.

Required profile

• 8+ years of experience in Finance/Controlling/FP&A positions.
• Experience in the pharmaceutical or biotechnology industry.
• Demonstrable career progression in global companies with experience across different geographical regions.
• Fluency in English, written and spoken, is mandatory.
• Desirable: advanced degree in a scientific discipline and/or MBA.

Required skills

• Strong technology and Microsoft Office skills: MS Excel, PowerPoint, SAP, Power BI.
• Ability to use AI models and emerging technologies to inform business decisions.